| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | CHIEF EXECUTIVE OFFICER, Director | Common Stock | 353K | $5.55M | $15.74 | Feb 16, 2024 | Direct |
| Scholar Rock Holding Corp | CHIEF EXECUTIVE OFFICER, Director | Stock Option (Right to Buy) | 286K | Feb 12, 2024 | Direct | ||
| Disc Medicine, Inc. | Director | Stock Option (Right to Buy) | 7K | Dec 29, 2022 | Direct | ||
| ACCELERON PHARMA INC | EVP, Research and Development | Common Stock | 0 | $29.37 | Nov 19, 2021 | Direct | |
| ACCELERON PHARMA INC | EVP, Research and Development | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | Feb 16, 2024 | 1 | -$183K | 4 | Feb 20, 2024 | CHIEF EXECUTIVE OFFICER, Director |
| SRRK | Scholar Rock Holding Corp | Feb 12, 2024 | 2 | $0 | 4 | Feb 13, 2024 | CHIEF EXECUTIVE OFFICER, Director |
| SRRK | Scholar Rock Holding Corp | Feb 13, 2023 | 2 | $0 | 4 | Feb 15, 2023 | CHIEF EXECUTIVE OFFICER |
| IRON | Disc Medicine, Inc. | Dec 29, 2022 | 1 | $0 | 4 | Jan 3, 2023 | Director |
| IRON | Disc Medicine, Inc. | Dec 29, 2022 | 0 | $0 | 3 | Jan 3, 2023 | Director |
| SRRK | Scholar Rock Holding Corp | Sep 20, 2022 | 1 | $0 | 4 | Sep 22, 2022 | CEO-Elect |
| SRRK | Scholar Rock Holding Corp | Sep 20, 2022 | 0 | $0 | 3 | Sep 22, 2022 | CEO-Elect |
| XLRN | ACCELERON PHARMA INC | Nov 19, 2021 | 3 | $0 | 4 | Nov 22, 2021 | EVP, Research and Development |